Article
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.
Breast cancer research and treatment - 1 Nov 2015
Ross Jeffrey S, Ali Siraj M, Wang Kai, Khaira Depinder, Palma Norma A, Chmielecki Juliann, Palmer Gary A, Morosini Deborah, Elvin Julia A, Fernandez Sandra V, Miller Vincent A, Stephens Philip J, Cristofanilli Massimo
Abstract excerpt
Inflammatory breast cancer (IBC) is a distinct clinicopathologic entity that carries a worse prognosis relative to non-IBC breast cancer even when matched for standard biomarkers (ER/PR/HER2). The objective of this study was to identify opportunities for benefit from targeted therapy, which are not currently identifiable in the standard workup for advanced breast cancer. Comprehensive genomic profiling on 53 IBC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
